Table 2. Lorazepam prescription and monitoring
|
Patients, n (%)
|
| Lorazepam prescription |
|
| No |
19 (18.6) |
| Yes |
83 (81.4) |
| Lorazepam administered |
|
| No |
38 (46.0) |
| Yes |
45 (54.0) |
| Indication documented |
|
| No |
48 (57.8) |
| Yes |
35 (42.2) |
| Review date set |
|
| No |
14 (13.7) |
| Yes |
88 (86.3) |
| at <1 week |
5 (5.5) |
| at 1-4 weeks |
27 (30.5) |
| at 4-12 weeks |
44 (50.0) |
at 1 year
|
12 (14.0)
|
|
